Informed consent for exchange blood transfusions in sickle cell disease
Tina Jegede Modern matron, Whittington Hospital NHS Trust, London
Heather Rawle Clinical health psychologist, Haematology Department, Guy’s and St Thomas’ NHS Foundation Trust, London
This article examines the importance of information giving and its role in gaining informed consent from patients with sickle cell disease requiring exchange blood transfusion for the management of stroke. The rationale for the use of exchange blood transfusion in patients with sickle cell disease who have had a stroke is explained. The impact of stroke on cognition is highlighted and the implications for informed decision making are considered. Other factors such as communicating risk are discussed.
Nursing Standard. 23, 4,44-49. doi: 10.7748/ns2008.10.23.4.44.c6676Correspondence
This article has been subject to double blind peer review